Abstract
Cerebral ischemia is characterized by obvious inflammatory cell aggregations, up-regulation of cytokine expression, and increased expression of intercellular adhesion molecules. Like systemic bacterial infections, cerebral injury is also associated with innate immunity, a specific immunologic response that utilizes Toll-like receptors (TLRs). The involvement of TLRs in cerebral ischemia is now being confirmed using animal models. Recent reports reveal that mice that lack TLR2 and TLR4 show improved stroke outcomes and that TLR2 and 4 may contribute to neuronal injury that occurs after cerebral ischemia. In this review, we have summarized these recent reports concerning the association of TLRs with cerebral ischemia.
Keywords: Cerebral ischemia, inflammation, innate immunity, mouse, middle cerebral artery occlusion (MCAO), Toll-like receptor (TLR), HMGB1, HSP60, IFN-, IRF3, lipopolysaccharide (LPS), microglia, middle cerebral artery occlusion, MMP, MyD88, neuron, NF-B, pathogenassociated molecular patterns (PAMPs), pattern-recognition receptor (PPR), TLR2, TLR3, TLR4, TLR9, TNF-, Toll/IL-1 receptor (TIR), TRIF
Central Nervous System Agents in Medicinal Chemistry
Title: Involvement of Toll-like Receptors in Ischemia-induced Neuronal Damage
Volume: 11 Issue: 2
Author(s): Junya Hamanaka and Hideaki Hara
Affiliation:
Keywords: Cerebral ischemia, inflammation, innate immunity, mouse, middle cerebral artery occlusion (MCAO), Toll-like receptor (TLR), HMGB1, HSP60, IFN-, IRF3, lipopolysaccharide (LPS), microglia, middle cerebral artery occlusion, MMP, MyD88, neuron, NF-B, pathogenassociated molecular patterns (PAMPs), pattern-recognition receptor (PPR), TLR2, TLR3, TLR4, TLR9, TNF-, Toll/IL-1 receptor (TIR), TRIF
Abstract: Cerebral ischemia is characterized by obvious inflammatory cell aggregations, up-regulation of cytokine expression, and increased expression of intercellular adhesion molecules. Like systemic bacterial infections, cerebral injury is also associated with innate immunity, a specific immunologic response that utilizes Toll-like receptors (TLRs). The involvement of TLRs in cerebral ischemia is now being confirmed using animal models. Recent reports reveal that mice that lack TLR2 and TLR4 show improved stroke outcomes and that TLR2 and 4 may contribute to neuronal injury that occurs after cerebral ischemia. In this review, we have summarized these recent reports concerning the association of TLRs with cerebral ischemia.
Export Options
About this article
Cite this article as:
Hamanaka Junya and Hara Hideaki, Involvement of Toll-like Receptors in Ischemia-induced Neuronal Damage, Central Nervous System Agents in Medicinal Chemistry 2011; 11 (2) . https://dx.doi.org/10.2174/187152411796011312
DOI https://dx.doi.org/10.2174/187152411796011312 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Combination of 3D-QSAR Modeling and Molecular Docking Approach for the Discovery of Potential HIF Prolyl Hydroxylase Inhibitors
Medicinal Chemistry Artemisia Species as a New Candidate for Diabetes Therapy: A Comprehensive Review
Current Molecular Medicine Evaluating Oxidative Stress in Human Cardiovascular Disease: Methodological Aspects and Considerations
Current Medicinal Chemistry Targeting Small Arteries of Hypertensive Status with Novel ATP-Sensitive Potassium Channel Openers&#
Current Vascular Pharmacology Raloxifene and Cardiovascular Health: Its Relationship to Lipid and Glucose Metabolism, Hemostatic and Inflammation Factors and Cardiovascular Function in Postmenopausal Women
Current Pharmaceutical Design Production and Degradation of Oxygen Metabolites During Inflammatory States in the Human Lung
Current Drug Targets - Inflammation & Allergy The Effect of SEX/Gender on Cardiovascular Pharmacology
Current Pharmaceutical Design Regulators of Chemokine Receptor Activity as Promising Anticancer Therapeutics
Current Cancer Drug Targets Topical Use of Sucralfate in Epithelial Wound Healing: Clinical Evidence and Molecular Mechanisms of Action
Recent Patents on Inflammation & Allergy Drug Discovery Morphofunctional Aspects of the Blood-Brain Barrier
Current Drug Metabolism Effects of Synthetic Peptides on the Inflammatory Response and their Therapeutic Potential
Mini-Reviews in Medicinal Chemistry Integrin Signaling Networks in the Pathobiology of Vascular Smooth Muscle Cells
Vascular Disease Prevention (Discontinued) A Link Between Chemical Structure and Biological Activity in Triterpenoids
Recent Patents on Anti-Cancer Drug Discovery Optical Coherence Tomography for Complete Management of Patients with Diabetic Retinopathy
Current Diabetes Reviews Lost in Translation: What is Limiting Cardiomyoplasty and Can Tissue Engineering Help?
Current Stem Cell Research & Therapy Prognostic Relevance of Metabolic Approach in Patients with Heart Failure
Current Pharmaceutical Design Oxidative Stress in the Molecular Mechanism of Pathogenesis at Different Diseased States of Organism in Clinics and Experiment
Current Drug Targets - Inflammation & Allergy Gas Bioengineering Using Hemoglobin-Vesicles For Versatile Clinical Applications
Current Pharmaceutical Design Oxidative Stress, Antioxidants, and Endothelial Function
Current Medicinal Chemistry Metaflammation: Tissue-Specific Alterations of the NLRP3 Inflammasome Platform in Metabolic Syndrome
Current Medicinal Chemistry